Aimmune Therapeutics (AIMT) Q4 2020 Earnings

25FebExpected
May 20
Jul 20
Q3 2020
Q4 2020
-1.34
-1.22
-1.1
-0.98

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Aimmune Therapeutics (AIMT) will report earnings of for Q4 2020 on February 25, 2021.

0 Comments

Share your thoughts